This week in Healthcare: Companies on an acquisition spree to accelerate their capability expansion

Hospital and Healthcare
HEAL Software Inc. announces partnership with Nous Infosystems 
Nous and HEAL are engaged in the joint development of a preventive healing solution to support customers operating in the Microsoft Azure Cloud environment. Read More>>
Early risk identification at core of innovative kidney care partnership between Renalytix, DaVita 
This clinical-grade program will deliver advanced early-stage prognosis and risk stratification, combined with actionable care management right to the primary care level where most kidney disease patients are being seen. Read More>>
Quest Diagnostics ties up with Hackensack Meridian Health 
Quest Diagnostics will manage laboratory operations and perform reference testing for 11 Hackensack Meridian Health hospitals under the long-term full laboratory management agreement. Read More>>

Mergers & Acquisitions
New York Life acquires Cigna businesses 
The $6.3 billion acquisition will strengthen New York Life’s position to continue to deliver financial security to individuals, families, and business owners. Read More>>
Centene to acquire Magellan Health in $2.2B deal 
The acquisition will help Centene enhance care for members with chronic illnesses and to advance its specialty care capabilities. Read More>>
UnitedHealth to buy Change Healthcare for nearly $8 billion to boost tech services 
The all-cash deal allows UnitedHealth to increase its capabilities with Change’s data and analytics platform-augmenting offerings. Read More>>
Aspen Dental Management acquires ClearChoice Management Services 
The ClearChoice acquisition caps off an impressive year of growth for Aspen, which now supports health and wellness practices across dental care, urgent care, and medical aesthetics. Read More>>

Executive Movement
Tenet appoints Cecil Haney to its board of directors  
Haney is a retired four-star Admiral, who completed 38 years of service in the U.S. Navy. He served as commander of the U.S. Strategic Command, where he was responsible for strategic capabilities involving nuclear forces, missile defense, space and cyberspace. Read More>>
UPMC Western Maryland introduces new vice president, medical affairs 
Dr. Simmons is a leader in managing the care of infectious disease patients and has earned several awards, including Fellow of the Year in 2011 by WVU Hospitals/Robert C. Byrd Health Science Center. Read More>>
Symvivo Corporation announces collaboration with Merck 
The agreement builds on Symvivo’s efforts to develop the bacTRL™ platform across a range of diverse and important indications. Read More>>
Myovant pops 20% on Pfizer drug collaboration 
Myovant will receive up to $4.2 billion, including an upfront payment of $650 million, $200 million in potential regulatory milestones for US Food and Drug Administration (FDA) approvals for relugolix combination tablet in women’s health. Read More>>
Incyte and Cellenkos enter into global development collaboration agreement for CK0804 
The agreement builds on This collaboration will support Incyte’s commitment to developing new therapeutic options designed to improve and expand treatment options for patients with MF. Read More>>

Centre Setup and Expansion
Pfizer Pharmaceutical, AstraZeneca and Amazon to build new innovation laboratory in Israel 
The Innovation Lab will have a budget of 10 million dollars, will be in the Rehovot Science Park and will begin operations in 2021. Read More>>

Merger and Acquisitions
MilliporeSigma acquires AmpTec to expand mRNA capabilities for vaccines, treatments and diagnostics
By combining AmpTec’s PCR-based mRNA technology MilliporeSigma can provide a truly differentiated and integrated offering across the mRNA value chain, significantly decreasing supply chain complexity and enhance speed-to-market. Read More>>
Angelini Pharma acquires Arvelle Therapeutics for $960 million
Angelini Pharma will have the exclusive license to commercialise cenobamate in the European Union and other countries in the European Economic Area (Switzerland and the United Kingdom). Read More>>
Collagen Matrix acquires the GUIDOR® Synthetic Bone Graft & Membrane business from Sunstar
GUIDOR’s synthetic technologies will complement Collagen Matrix’s proprietary, collagen-based products, enabling it to offer a comprehensive portfolio of regenerative medicine products to both its OEM customers as well as its global Contract Development customers. Read More>>
Eli Lilly to buy New York drugmaker for up to $1B
The acquisition will help Eli Lilly create a gene therapy program, which will be anchored by Prevail’s portfolio of clinical stage and preclinical neurodegenerative disease drugs. Read More>>

Executive Movement
Pair of new non-exec directors strengthens pharma group Vectura’s board
Jeanne Hecht and Jeanne Thoma took up their roles at the firm, which develops inhalable dry-powder drugs that treat lung conditions such as asthma, emphysema and chronic bronchitis.  Read More>>
Executive Movement
Pacific Biosciences announces appointments of Mark Van Oene as chief operating officer and Peter Fromen as chief commercial officer 
Mr. Van Oene joins from Illumina. He was responsible for the development and implementation of the company’s commercial strategy and oversaw worldwide sales and services. Mr. Fromen also joins from Illumina. He was responsible for product management, market development, and market strategy across Genetic Disease Research and Testing, Population Genomics, Health Systems and Consumer Genomics. Read More>>

Merger & Acquistions
PerkinElmer to buy Oxford Immunotec for $591M
Through this Acquisition, PerkinElmer will grow its portfolio of advanced infectious disease testing solutions to include tuberculosis detection to better serve customers around the world. Read More>>
CooperSurgical acquires Embryo Options
The acquisition will help CooperSurgical in automated billing and streamlined management of cryo-preserved embryos, eggs, and sperm, resulting in increased collections, decreased specimen abandonment, and a reduced cost to manage cryo-inventory. Read More>>
Stratasys completes Origin buyout to fuel 3d printing
Stratasys benefits from Origin’s proprietary resin-based Programmable PhotoPolymerization technology used in its manufacturing-grade 3D printer, Origin One. Read More>>
Hologic to acquire diagnostic tests provider Biotheranostics for $230m
The acquisition will help to fast-track Hologic’s entry into the oncology growth market. Biotheranostics develops diagnostic, prognostic, and predictive tests, which support physicians in cancer patient treatment. Read More>>
Fresenius buys NMC’s fertility business for €430m
The new platform will serve as an accelerator for holistic and interdisciplinary patient care, while leveraging significant synergies. Read More>>
Thermo Fisher announces acquisition of Phitonex
Phitonex’s product offering will enable Thermo Fisher to offer greater flow cytometry and imaging multiplexing capabilities to meet evolving customer needs in protein and cell analysis research. Read More>>

Henry Schein completes joint venture with Casa Schmidt
The joint venture will advance the mutual goal of helping health care professionals operate more efficient practices by providing new solutions and technologies for the ultimate benefit of patients. Read More>>
Konica Minolta partners with for workflow and MPS applications
The partnership will enhance customer experience by better distributing application, network and data traffic efficiently and securely, particularly in sectors where zero downtime is critical. Read More>>
Headlines From The Startup World
Startup Spotlight
Latest Insights & Reports
Becton Dickinson & Company Account Intelligence Report: Becton Dickinson has made several strategic partnerships for real-time PCR detection kit, acquired CUBEX for drug management, and introduced BD Veritor for antigen testing. Click here to read here. 
University of California Account Intelligence Report: UoC is currently engaging with solution providers for virtual student engagements and adoption of advanced technologies through their courses. Click here to read more. 
Here’s what’s new on our Sales Intelligence Platform
View Number of ‘Active Workflows’
View the number of active workflows with each service provider in the outsourcing section to assess the relationship strength. 
View All Updates
Copyright © *|CURRENT_YEAR|* Zinnov, All rights reserved.

We are located at: *|HTML:LIST_ADDRESS_HTML|* *|END:IF|*

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

What you should do now

  1. Request a Demo and see how Draup can maximize the impact of your go-to-market teams with AI-driven sales intelligence.
  2. Read more free material about sales intelligence topics in our blog.
  3. If you know someone who’d enjoy this page, share it with them via email, LinkedIn, Twitter, or Facebook.